The Dural Graft market to get smarter with smart devices, reaching USS 1.1 Bn with a 6% CAGR during the forecast period (2019-2031)

The pharmaceutical industry is making use of AI for discovering new-fangled drugs. January 2020 witnessed the invention of the very first drug molecule using AI, whose patent lay with Japanese and British scientists. The medicine is being used for treating OCD (obsessive-compulsive disorder). Likewise, several promising formulas are being discovered as an outcome of AI-enabled lab experimenting. This would be how the pharmaceutical arm of the healthcare vertical look shortly.

The global dural graft market is expected to reach USS 1.1 Bn by the year 2031.Persistence Market Research predicts that, the global dural graft market will exhibit a 6% CAGR during the forecast period (2019-2029).

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25285

Global demand for dural graft is expected to grow significantly, owing to rising burden of neurosurgical diseases leading to increasing cranial and spinal duraplasty, and rapid technological advancements in dural graft products. Moreover, increasing global neurosurgical workforce, extensive clinical research, and increasing demand for CNS dural repair are responsible for increasing the adoption of dural graft products. For instance, in 2004, the World Health Organization (WHO) estimated that, there were 33,193 neurosurgeons worldwide, including trainees. Whereas, in 2015, this number rose to approximately 49,940 neurosurgeons, with a 4% total growth, worldwide.

Company Profiles:

Cook Medical.
Integra Lifesciences Corporation
B Brown
Cousin Biotech,
Natus Medical Incorporated
Tissuemed Ltd,
Your GmbH
Stryker Corporation
Medtronic Plc.
Johnson & Johnson,
Aesculap, Inc.
Baxter International Inc

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/25285

Key Takeaways of Dural Graft Market Study

By product type, synthetic dural graft along with xenogeneic dural graft are expected to gain traction during the forecast period.
Technological advancements in material science of dural graft products in North America and Europe are expected to contribute to the significant dominance of these regions during the forecast period.
Brain and spine tumor applications are expected to hold more than 50% share in the global dural graft market.
Synthetic polymer material is expected to gain significant traction and experience 2X demand by 2029.
Leading dural graft manufacturing companies are partnering with innovative product developers and specialized distributors to strengthen their market position.
Rising healthcare expenditure and increasing neurosurgeon workforce density in East Asia are expected to offer significant opportunities for market growth.
"Increasing scientific evidence from industry-led clinical trials and technological advancements in dural graft products are expected to support the significant adoption of synthetic nanofibrous dural grafts." says a PMR analyst.

Brain and Spinal Tumor Application Dominating Dural Graft Market

Prevalence of CNS tumors due to neurological conditions is growing rapidly. Chiari malformation and spinal cord tumor-related neurosurgical procedures requiring dural grafts for surgeries are becoming more frequent. Growing risk of such neurological conditions demands neurosurgical procedures along with duraplasty for effective and safe treatment outcomes. For instance, in 2018, more than 50% of dural grafts were used in cranial and spine tumor operations. This high proportion is estimated to continue in the future.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/25285

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the dural graft market in its latest study, presenting historical demand assessment from 2014-2018 and projections for 2019-2029, on the basis of product type (xenogeneic dural graft, synthetic dural graft, autologous dural graft, and allogeneic dural graft), application (brain and spine tumor, traumatic brain and spine injury, cerebrospinal fluid (CSF) accumulation, cerebrovascular accident, epilepsy, and others), material (bovine pericardium, autologous pericardium, synthetic polymers, ligamentum nuchae, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and clinics), across seven key regions.

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.